$GDMK Global Diversified Marketing Group Inc. Discusses Its

New Post Public Reply Private Reply Replies (0) Message Board
Lee Adams
188
$GDMK Global Diversified Marketing Group Inc. Discusses Its Diversification and Expansion Strategy with The Stock Day Podcast

Phoenix, Arizona--(Newsfile Corp. - June 1, 2020) - The Stock Day Podcast welcomed Global Diversified Marketing Group Inc. (OTC Pink: GDMK) ("the Company" , a company that operates as a food and snack manufacturer, importer, and distributor through its subsidiary in the United States, Canada, and Europe. President and CEO of the Company, Paul Adler, joined Stock Day host Everett Jolly.

Jolly began the interview by asking Adler about the Company's growth strategy. "What we're basically looking to do is expand our brick and mortar business," explained Adler. "Right now, we're distributing nationwide directly with major retailers," he continued, adding that the Company recently signed an agreement with Asian American Trade Associations Council (AATAC) in an effort to expand their line of Biscottelli Italian Croissants into the C-Store channel nationwide.

Jolly then asked whether the Company more closely identifies as an importer and distributor or as a manufacturer. "We are mainly classified as a manufacturer/importer and distributor," said Adler. He then explained that the Company is always looking for unique products which will eventually be contract-manufactured along with their trademark branded products. "We import them to the US and distribute them directly to many retailers," said Adler, noting that many companies in the same space choose to outsource many of these steps, allowing the Company to stand out as a more diversified contender.

The conversation then turned to the launch of the Company's Amazon marketing program, which resulted in a 151% increase in sales. "For the past twelve months, we've been expanding into eCommerce, and the eCommerce has been doing phenomenal for us," shared Adler. "As far as recently, in January, the number started skyrocketing," he added. "We believe that this is a very sustainable model going forward to diversify ourselves into an eCommerce business," said Adler, noting that the Company plans to continue expanding to additional eCommerce platforms.

"Are you thinking of any new products that you'll be bringing online?", asked Jolly. Adler shared that the Company launched a shelf-stable macaron product prior to the COVID-19 pandemic. "Usually this item is a refrigerated item," he explained, noting the uniqueness of the product. "We were able to bring it under our brand and launch as a soft launch in early February," said Adler. "We decided to do a full-scale distribution going forward over the next several months."

Jolly then asked how the Company's segment varies from others in the industry. "We're an essential segment," said Adler. "Over the last six months, the snacking percentage in growth has increased four-fold."

To close the interview, Adler shared that the Company will continue forward with a strong focus on its diversification, which they plan to achieve by raising additional capital and completing numerous acquisitions.

To hear Paul Adler's entire interview, follow the link to the podcast here: https://audioboom.com/posts/7596160-global-di...ategy-with

About Global Diversified Marketing Group

Headquartered in Island Park, NY - Global Diversified Marketing Group Inc operates as a food and snack manufacturer, Importer & distributor through its subsidiary in the United States, Canada and Europe. The company operates through snacks segment. The snacks segment offers Italian Wafers, Italian filled croissants, French Madeleines, Wafer Pralines, shelf stable Macarons and other gourmet snacks. The company sells its products direct and through various distribution channels comprising specialty, grocery retailers, food-service distributors, DSD as well as vending, pantry and micro market segment.

Safe Harbor Statement

Certain statements in this announcement are forward-looking statements and are prospective in nature. Forward-looking statements are not based on historical facts, but rather on current expectations and projections about future events, many of which, by their nature, are inherently uncertain and outside of the Company's control and are therefore subject to risks and uncertainties which could cause actual results to differ materially from the future results expressed or implied by the forward-looking statements.

These statements generally can be identified by the use of forward-looking words such as "may", "should", "will", "could", "intend", "estimate", "plan", "anticipate", "expect", "believe" or "continue", or the negative thereof or similar variations. Forward-looking statements in this news release include, but are not limited to, information concerning the ability of the Company to successfully achieve business objectives, and expectations for other economic, business, and/or competitive factors. Those assumptions and factors are based on information currently available to the Company. Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information and statements are the following: the ability of the Company to develop the Company's brand and meet its growth objectives, the ability of the Company to complete acquisitions that are accretive to the Company's revenue, the ability of the Company to obtain and/or maintain licenses to operate in the jurisdictions in which it operates or in which it expects or plans to operate. Should one or more of these risks, uncertainties or other factors materialize, or should assumptions underlying the forward-looking information or statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Readers should not place undue reliance on forward-looking statements and forward-looking information. The forward-looking information contained in this release is made as of the date hereof and the Company assumes no obligation to update or revise any forward-looking statements or forward-looking information that are incorporated by reference herein, whether as a result of new information, future events or otherwise, except as required by applicable securities laws.

The foregoing statements expressly qualify any forward-looking information contained herein. All subsequent written and oral forward-looking information and statements attributable to the Company or persons acting on its behalf is expressly qualified in its entirety by this notice.

Contact:
Global Diversified Marketing Group Inc
Paul Adler, Chairman, President & CEO
800-550-5996
paul@gdmginc.com
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Harbour BioMed Joins Stock Connect, Boosts Investor Access

Updated Category News Views 3

The Big Leap: Harbour BioMed Joins Stock Connect Well, if this ain't something to get excited about—Harbour BioMed just snagged a spot on the Stock Connect roster. This step isn't just ceremonial. We're talking about real access for mainland Chinese investors to dive directly into the shares of Harbour BioMed (HKEX: 02142.HK) through the Shanghai-Hong Kong and...

Continue Reading
Park Systems Expands in the Pacific Northwest

Updated Category News Views 3

Strategic Move into Hillsboro Sparks Industry Buzz Park Systems, already a heavyweight in the nanometrology arena, just made a bold play with the opening of its latest regional office. Nestled in the tech-centric town of Hillsboro, Oregon, this hub is set to redefine how they handle technical support and customer management across the Pacific Northwest. It's like they're...

Continue Reading
DUVA ONE Sleep Earbuds: Real-Time Innovation Debuts

Updated Category News Views 3

While You Dream, DUVA ONE Works Here's the scoop: DUVA just took sleep tech to another level with their DUVA ONE earbuds launched at Berlin's IFA 2026. These aren't just any earbuds; they're engineered to actually do something while you're sleeping. DUVA ONE senses what’s happening during your snooze session and adjusts right on the fly. The Night Patrol: In-Ear and...

Continue Reading
Roborock Fuels Market Surge with 27.6% Revenue Boost

Updated Category News Views 2

Roborock's Rocket-Like Ascent in Global Markets Call me impressed, but Roborock is really hitting its stride. The company's been on a tear, pulling in RMB 10.084 billion during the first half of 2026—a remarkable 27.6% bump from last year. Not just content with the revenue surge, they also saw net profits jump 45.6%, making it pretty clear that they're not just playing...

Continue Reading
York Space Systems Faces Class Action Over Misleading IPO

Updated Category News Views 2

York Space Systems Under the Legal Spotlight Ever get that feeling when something just doesn’t sit right? Like a burr under the saddle, York Space Systems is now grappling with a class action lawsuit that's throwing a heap of shade on its recent moves. What’s at play? Bronstein, Gewirtz & Grossman, LLC, a law firm that seems to have a nose for corporate messes, has...

Continue Reading
Summit Tackles BRI Infrastructure's Role in Global SDGs

Updated Category News Views 3

A Bold Gathering with Lofty Goals Ever watch a room of world leaders debate the finer nuances of sustainable infrastructure? That's something Singapore pulled off on September 6, 2026, with the Second Global Business Summit on Belt and Road Infrastructure Investment. These aren't just any ordinary suits sitting around in a conference room. We're talking about a dynamic...

Continue Reading
Clover's RSV Combo Vaccine Shows Promise in Trials

Updated Category News Views 3

In the biotech world, there's always a race. Clover Biopharmaceuticals is making strides with their RSV+hMPV vaccine candidate, especially for the elderly. Imagine those big leaps in development—all boosted by recent results from a Phase 2 trial down under in Australia. Key Findings of the Trial Immunogenicity Insights They're not messing around with these findings. The...

Continue Reading
Hims & Hers Faces Class Action: Investors Beware

Updated Category News Views 2

Allegations and Legal Pressure There's trouble brewing in the land of health and wellness apps, with Hims & Hers Health, Inc. (NYSE:HIMS) taking center stage. Slap on your glasses, folks, because this one's a doozy. A class-action lawsuit has exploded against the company and some of its officers—allegations flying as they focus on serious accusations of misleading...

Continue Reading
Bad Bunny Super Bowl Halftime Show Sweeps 7 Emmy Wins

Updated Category News Views 6

An Unprecedented Performance: A Halftime Show for the Ages Hold onto your hats, folks—Bad Bunny and his Super Bowl LX Halftime Show have taken home a jaw-dropping seven Emmys at the 78th Emmy Awards. This is uncharted territory for any Super Bowl Halftime Show. Never before has a halftime spectacle swept the Emmys like this. We’re talking about categories such as...

Continue Reading
XiamenAir Takes Off with Fujian-London Link

Updated Category News Views 2

A New Dawn for Fujian Travelers Here's a nugget to chew on: XiamenAir's first-ever direct flight from Xiamen to London had its moment in the spotlight. This isn't just another intercontinental flyby—it's a game-changer for folks in Fujian looking to hop across the pond without the layover hassle. With Flight MF821 touching down in Heathrow early on September 6th, this...

Continue Reading

Top 5 Most Recently Viewed Articles

Big Screen Entertainment Group Unveils Big Screen Capital Fund

Updated Category News Views 138

Introducing Big Screen Capital Big Screen Entertainment Group (OTC:BSEG) has just announced the launch of its new funding subsidiary, Big Screen Capital. This exciting development is set to finance a range of creative projects, including the establishment of the Big Film Fund, as well as two upcoming films and advancements in medical technology. With this strategic move,...

Continue Reading
Air Products Faces Integrity Challenges: A Call for Change

Updated Category News Views 129

Understanding the Recent Calls for Change at Air Products Mantle Ridge has taken a bold step by issuing a shareholder letter that highlights critical concerns regarding Air Products and Chemicals, Inc. The organization, which owns approximately $1.3 billion in shares of Air Products, has pointed out various omissions and misleading statements from the company’s...

Continue Reading
Navigating Key Market Shifts in H2 2026: A Crucial Period

Updated Category News Views 5

The Intensity of Mid-2026: Traders Brace for Impact Traders are steeling themselves for July's rollercoaster of central bank decisions. This isn't just another season; it's a potential market earthquake. When you've got the European Central Bank, Bank of England, and Federal Reserve all signaling rate announcements within days, it's time to pay more than a little...

Continue Reading
Summary of Recent Extraordinary General Meeting Outcomes

Updated Category News Views 158

Results of Extraordinary General Meeting Announcement German High Street Properties A/S is pleased to present the results from the extraordinary general meeting that took place. This meeting marks a significant moment for the company and its shareholders as they come together to discuss essential matters affecting the company's future. Date and Purpose of the Meeting The...

Continue Reading
Tectonic Therapeutics Advances TX45 for Heart Failure Treatment

Updated Category News Views 166

Tectonic Therapeutics Advances TX45 for Heart Health Tectonic Therapeutic, Inc. (NASDAQ: TECX), an innovative biotechnology company, has announced promising outcomes from its Phase 1a trials, which could lead to significant progress in treating Group 2 Pulmonary Hypertension in patients experiencing Heart Failure with Preserved Ejection Fraction (PH-HFpEF). The results...

Continue Reading